Moderna reveals 94.5% efficacy for its corona vaccine
Third major COVID vaccine candidate comes out of Phase III trials with an average efficacy of 94.5%
Third major COVID vaccine candidate comes out of Phase III trials with an average efficacy of 94.5%
As the UK government continues to pump millions of pounds into the development of new nuclear facilities, Science Editor Lily Shepherd discusses whether this is really the right approach for the UK energy mix.
Science editor Lily Shepard reports on the trend towards modular, smaller reactors that could rapidly boost nuclear power output
Ioana Esanu (writer) and Liyang Zhao (video producer) tackle a science question that's on everyone's mind at the moment.
Scientists at the University of Science and Technology of China have succeeded in integrating a huge quantum key distribution (QKD) network
The Felix Science section launch their new series of pop science articles and videos, answering some of science's biggest questions
Vitamin D is being supplied to clinically vulnerable people in an attempt to protect them from COVID-19 symptoms
Science Editor Julia Dabrowska reports on the results of the BioNTech/Pfizer vaccine trials, the first candidate vaccine in the fight against COVID-19
Science Editor Lily Sheperd discusses the effect fo the US election on science
Tech Writer Shrey Bohra thinks Nvidia should not be allowed to acquire ARM, in detriment to European tech industry and security
Most recent iteration of UK's fusion reactor successfully ignited for the first time
Test & trace data has been (on a case-by-case basis) provided to the police, to help ensure that those legally required to self-isolate are indeed doing so.